Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
April 16, 2010
Self-specific CD8+ T cells maintain a semi-naive state following lymphopenia-induced proliferation
Lisa D S Johnson, Stephen C Jameson
Plos One
|
August 11, 2012
TGF-β sensitivity restrains CD8+ T cell homeostatic proliferation by enforcing sensitivity to IL-7 and IL-15
Lisa D S Johnson, Stephen C Jameson
Immunologic Research
|
April 17, 2008
Negative regulators in homeostasis of naïve peripheral T cells
Jaime F Modiano, Lisa D S Johnson, Donald Bellgrau
Anticancer Research
|
February 11, 2014
Histidine rich glycoprotein and cancer: a multi-faceted relationship
Lisa D S Johnson, Hadi A Goubran, Rami R Kotb
Clinical Chemistry
|
July 17, 2013
Quantification of a proteotypic peptide from protein C inhibitor by liquid chromatography-free SISCAPA-MALDI mass spectrometry: application to identification of recurrence of prostate cancer
Morteza Razavi, Lisa D S Johnson, Julian J Lum, et al.
The Journal of Experimental Medicine
|
February 4, 2009
The antigen-specific CD8+ T cell repertoire in unimmunized mice includes memory phenotype cells bearing markers of homeostatic expansion
Catherine Haluszczak, Adovi D Akue, Sara E Hamilton, et al.
Cancer Immunology, Immunotherapy : CII
|
September 14, 2021
The pivotal role of cytotoxic NK cells in mediating the therapeutic effect of anti-CD47 therapy in mycosis fungoides
Oleg Kruglov, Lisa D S Johnson, Angela Minic, et al.
Plos One
|
January 5, 2011
Polyfunctional T-cell responses are disrupted by the ovarian cancer ascites environment and only partially restored by clinically relevant cytokines
Eric Tran, Julie S Nielsen, Darin A Wick, et al.
NPJ Precision Oncology
|
July 19, 2023
Targeting CD47-SIRPa axis shows potent preclinical anti-tumor activity as monotherapy and synergizes with PARP inhibition
Hussein Al-Sudani, Ying Ni, Philip Jones, et al.
Frontiers in Immunology
|
March 13, 2025
Maplirpacept: a CD47 decoy receptor with minimal red blood cell binding and robust anti-tumor efficacy
Mithunah Krishnamoorthy, Ruth Seelige, Christopher R Brown, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Journal of Immunology (Baltimore, Md. : 1950)
|
April 16, 2010
Self-specific CD8+ T cells maintain a semi-naive state following lymphopenia-induced proliferation
Lisa D S Johnson, Stephen C Jameson
Plos One
|
August 11, 2012
TGF-β sensitivity restrains CD8+ T cell homeostatic proliferation by enforcing sensitivity to IL-7 and IL-15
Lisa D S Johnson, Stephen C Jameson
Immunologic Research
|
April 17, 2008
Negative regulators in homeostasis of naïve peripheral T cells
Jaime F Modiano, Lisa D S Johnson, Donald Bellgrau
Anticancer Research
|
February 11, 2014
Histidine rich glycoprotein and cancer: a multi-faceted relationship
Lisa D S Johnson, Hadi A Goubran, Rami R Kotb
Clinical Chemistry
|
July 17, 2013
Quantification of a proteotypic peptide from protein C inhibitor by liquid chromatography-free SISCAPA-MALDI mass spectrometry: application to identification of recurrence of prostate cancer
Morteza Razavi, Lisa D S Johnson, Julian J Lum, et al.
The Journal of Experimental Medicine
|
February 4, 2009
The antigen-specific CD8+ T cell repertoire in unimmunized mice includes memory phenotype cells bearing markers of homeostatic expansion
Catherine Haluszczak, Adovi D Akue, Sara E Hamilton, et al.
Cancer Immunology, Immunotherapy : CII
|
September 14, 2021
The pivotal role of cytotoxic NK cells in mediating the therapeutic effect of anti-CD47 therapy in mycosis fungoides
Oleg Kruglov, Lisa D S Johnson, Angela Minic, et al.
Plos One
|
January 5, 2011
Polyfunctional T-cell responses are disrupted by the ovarian cancer ascites environment and only partially restored by clinically relevant cytokines
Eric Tran, Julie S Nielsen, Darin A Wick, et al.
NPJ Precision Oncology
|
July 19, 2023
Targeting CD47-SIRPa axis shows potent preclinical anti-tumor activity as monotherapy and synergizes with PARP inhibition
Hussein Al-Sudani, Ying Ni, Philip Jones, et al.
Frontiers in Immunology
|
March 13, 2025
Maplirpacept: a CD47 decoy receptor with minimal red blood cell binding and robust anti-tumor efficacy
Mithunah Krishnamoorthy, Ruth Seelige, Christopher R Brown, et al.
Page
of 2